ArticleBMC cardiovascular disorders2025
Correlation of admission sodium levels with 28-Day and 1-year mortality in STEMI patients undergoing emergency PCI.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the association between serum sodium levels within 24 hours of admission and short-term (28-day) and medium-term (1-year) all-cause mortality in patients with ST-segment elevation myocardial infarction (STEMI) following emergency percutaneous coronary intervention (PCI).
methodsWe conducted a single-center retrospective cohort study including 532 patients with STEMI who underwent emergency PCI from January 2020 to January 2022. Patients were stratified into two groups based on admission serum sodium levels: <145 mmol/L (n=476) and ≥145 mmol/L (n=56). Restricted cubic spline models analyzed the non-linear relationship, and multivariable logistic regression assessed prognostic impact.
resultsAll-cause mortality rates were 2.2% (12/532) at 28 days and 2.8% (15/532) at 1 year. Restricted cubic spline analysis revealed a U-shaped association between serum sodium and mortality (P < 0.001), with an inflection point at 143 mmol/L. Subgroup analyses confirmed stability across age, gender, and comorbidities.
conclusionsAdmission hypernatremia (≥145 mmol/L) is significantly associated with increased 28-day and 1-year mortality risks in STEMI patients post-emergency PCI. Early sodium management may improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.